ArticleKidney & blood pressure research2022

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence.

Lorenzo A Calò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.